Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam for Pain After Third Molar Surgery
NCT02183051Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 1998
- Primary completion
- Oct 1998
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of meloxicam in postoperative pain (7 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Pain Intensity Difference. Started Apr 1998; status: completed.
02
Drugs
meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02183051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183051.